CBL-514

Caliway Presents CBL-514 Data Showing Reduced Weight Regain with GLP-1 Therapies

June 10, 2026 – Taipei, Taiwan Caliway Biopharmaceuticals announced new preclinical data demonstrating the potential of its proprietary fat-reduction...

By cGxPwire Editor
June 12, 2026

Bio-Pharma

Caliway Showcases CBL-514 Obesity Combination Data at ECO 2026

NEW TAIPEI CITY, Taiwan, May 18, 2026 Caliway Biopharmaceuticals unveiled new preclinical findings at the European Congress on Obesity...

By cGxPwire Editor
May 19, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

CBL-514

Caliway Presents CBL-514 Data Showing Reduced Weight Regain with GLP-1 Therapies

Caliway Showcases CBL-514 Obesity Combination Data at ECO 2026